The role of inflammatory cytokines in diabetic nephropathy

Juan F Navarro-González1, Carmen Mora-Fernández

  • 1Servicio de Nefrología, Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain. jnavgon@gobiernodecanarias.org

Insights

Chronic inflammation and specific cytokines like IL-6 are key in diabetic nephropathy development. Understanding cytokine genetics may reveal new therapeutic targets for this diabetes complication.

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Cytokines are crucial polypeptides that regulate inflammatory and immune responses.
  • Chronic low-grade inflammation and innate immune system activation are implicated in diabetes mellitus and its microvascular complications.
  • Specific inflammatory cytokines, including Interleukin-1 (IL-1), Interleukin-6 (IL-6), Interleukin-18 (IL-18), and Tumor Necrosis Factor-alpha (TNF-alpha), play roles in diabetic nephropathy.

Purpose of the Study:

  • To explore the role of inflammatory cytokines in the pathogenesis of diabetic nephropathy.
  • To investigate the significance of cytokine genetics, including combinatorial polymorphisms and functional variations, in susceptibility to diabetic nephropathy.
  • To identify potential therapeutic targets based on the role of cytokines in diabetic nephropathy.

Main Methods:

  • Review of existing literature on cytokines, inflammation, and diabetic nephropathy.
  • Analysis of the involvement of specific cytokines (IL-1, IL-6, IL-18, TNF-alpha) in disease development.
  • Examination of the contribution of genetic variations in cytokine genes to diabetic nephropathy susceptibility.

Main Results:

  • Inflammatory cytokines are significant mediators in the development and progression of diabetic nephropathy.
  • Cytokine genetics, particularly polymorphisms, are of interest for understanding susceptibility.
  • These findings highlight the link between inflammation, genetics, and diabetic kidney disease.

Conclusions:

  • Inflammatory cytokines are key players in the pathophysiology of diabetic nephropathy.
  • Genetic factors related to cytokines may influence an individual's susceptibility to diabetic nephropathy.
  • Targeting these cytokine pathways presents a potential strategy for future therapeutic interventions in diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.